小鼠抗CYB5R1單克隆抗體

Background:

NADH-cytochrome b5 reductases participate in a variety of physiological processes including biosynthesis of cholesterol, methemoglobin reduction of erythrocytes, elongation of fatty acids and metabolism of drugs. CYB5R1 (cytochrome b5 reductase 1), also known as NADH-cytochrome b5 reductase 1, B5R1, NQO3A2, humb5R2 or NAD(P)H:quinone oxidoreductase type 3 polypeptide A2, is a 305 amino acid single-pass membrane protein that contains one FAD-binding FR-type domain and belongs to the flavoprotein pyridine nucleotide cytochrome reductase family. Widely expressed, CYB5R1 binds FAD as a cofactor and is encoded by a gene located on human chromosome 1. Human chromosome 1 spans 260 million base pairs, contains over 3,000 genes, comprises nearly 8% of the human genome and houses a large number of disease-associated genes, including those that are involved in familial adenomatous polyposis, Stickler syndrome, Parkinson’s disease, Gaucher disease, schizophrenia and Usher syndrome.

Applications:

WB, IHC, IF

Name of antibody:

CYB5R1

Immunogen:

Fusion protein of human CYB5R1

Full name:

cytochrome b5 reductase 1 (CYB5R1)

Synonyms:

B5R.1; B5R1; B5R2; humb5R2; NQO3A2

SwissProt:

Q9UHQ9

IHC positive control:

adenocarcinoma of human endometrium tissue and human kidney tissue

IHC Recommend dilution:

30-150

WB Predicted band size:

34 kDa

WB Positive control:

A549 cell lysate

WB Recommended dilution:

500-2000